Trial intelligence / Profile preview

Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients

NCT00512811Phase 3Completed

Sponsor
Baqiyatallah University of Medical Sciences
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of furosemide in bronchiolitis, acute respiratory failure (ARF), Dyspnea, sponsored by Baqiyatallah University of Medical Sciences. Status: completed.

02

Drugs

furosemide
03

Conditions

bronchiolitisacute respiratory failure (ARF)Dyspnea

Beyond the preview

Go deeper on NCT00512811.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00512811.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call